Literature DB >> 33907061

Diagnosis and Management of Sitosterolemia 2021.

Hayato Tada1, Akihiro Nomura1, Masatsune Ogura2, Katsunori Ikewaki3, Yasushi Ishigaki4, Kyoko Inagaki5, Kazuhisa Tsukamoto6, Kazushige Dobashi7, Kimitoshi Nakamura8, Mika Hori9, Kota Matsuki10, Shizuya Yamashita11, Shinji Yokoyama12, Masa-Aki Kawashiri1, Mariko Harada-Shiba13.   

Abstract

Sitosterolemia is an inherited metabolic disorder characterized by increased levels of plant sterols, such as sitosterol. This disease is caused by loss-of-function genetic mutations in ATP-binding cassette (ABC) subfamily G member 5 or member 8 (ABCG5 or ABCG8, respectively), both of which play important roles in selective excretion of plant sterols from the liver and intestine, leading to failure to prevent absorption of food plant sterols. This disorder has been considered to be extremely rare. However, accumulated clinical data as well as genetics suggest the possibility of a much higher prevalence. Its clinical manifestations resemble those observed in patients with familial hypercholesterolemia (FH), including tendon xanthomas, hyper LDL-cholesterolemia, and premature coronary atherosclerosis. We provide an overview of this recessive genetic disease, diagnostic as well as therapeutic tips, and the latest diagnostic criteria in Japan.

Entities:  

Keywords:  ABCG5; ABCG8; Familial hypercholesterolemia; Sitosterolemia

Mesh:

Substances:

Year:  2021        PMID: 33907061      PMCID: PMC8326170          DOI: 10.5551/jat.RV17052

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  54 in total

1.  Clinical and molecular genetic analysis of a family with sitosterolemia and co-existing erythrocyte and platelet abnormalities.

Authors:  Yanhua Su; Zhaoyue Wang; Haiyan Yang; Lijuan Cao; Fang Liu; Xia Bai; Changgeng Ruan
Journal:  Haematologica       Date:  2006-10       Impact factor: 9.941

2.  Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively.

Authors:  K Lu; M H Lee; S Hazard; A Brooks-Wilson; H Hidaka; H Kojima; L Ose; A F Stalenhoef; T Mietinnen; I Bjorkhem; E Bruckert; A Pandya; H B Brewer ; G Salen; M Dean; A Srivastava; S B Patel
Journal:  Am J Hum Genet       Date:  2001-07-09       Impact factor: 11.025

3.  Ezetimibe reduces plant sterol accumulation and favorably increases platelet count in sitosterolemia.

Authors:  Rgia A Othman; Semone B Myrie; David Mymin; Louise S Merkens; Jean-Baptiste Roullet; Robert D Steiner; Peter J H Jones
Journal:  J Pediatr       Date:  2014-10-16       Impact factor: 4.406

4.  Clinical features, molecular characteristics, and treatments of a Chinese girl with sitosterolemia: A case report and literature review.

Authors:  Xueying Su; Yongxian Shao; Yunting Lin; Xiaoyuan Zhao; Wen Zhang; Minyan Jiang; Yonglan Huang; Chunhua Zeng; Li Liu; Xiuzhen Li
Journal:  J Clin Lipidol       Date:  2019-01-22       Impact factor: 4.766

5.  Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters.

Authors:  A K Bhattacharyya; W E Connor
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

6.  A case of sitosterolemia misdiagnosed as familial hypercholesterolemia: A 4-year follow-up.

Authors:  Wei Wang; Long Jiang; Pan-Pan Chen; Yue Wu; Peng-Yu Su; Lu-Ya Wang
Journal:  J Clin Lipidol       Date:  2017-11-11       Impact factor: 4.766

Review 7.  Sitosterolemia: diagnosis, investigation, and management.

Authors:  Joan Carles Escolà-Gil; Helena Quesada; Josep Julve; Jesús M Martín-Campos; Lídia Cedó; Francisco Blanco-Vaca
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

Review 8.  Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.

Authors:  Clive R Pullinger; John P Kane; Mary J Malloy
Journal:  Expert Rev Cardiovasc Ther       Date:  2003-05

Review 9.  Plant sterols and cardiovascular disease: a systematic review and meta-analysis.

Authors:  Bernd Genser; Günther Silbernagel; Guy De Backer; Eric Bruckert; Rafael Carmena; M John Chapman; John Deanfield; Olivier S Descamps; Ernst R Rietzschel; Karen C Dias; Winfried März
Journal:  Eur Heart J       Date:  2012-02       Impact factor: 29.983

Review 10.  Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan.

Authors:  Hiroshi Mabuchi
Journal:  J Atheroscler Thromb       Date:  2017-02-08       Impact factor: 4.928

View more
  7 in total

1.  Clinical characteristics of sitosterolemic children with xanthomas as the first manifestation.

Authors:  Jun Zhang; Qiu-Li Chen; Song Guo; Yan-Hong Li; Chuan Li; Ru-Jiang Zheng; Xue-Qun Luo; Hua-Mei Ma
Journal:  Lipids Health Dis       Date:  2022-10-13       Impact factor: 4.315

2.  Clinical and Genetic Analysis of a Family With Sitosterolemia Caused by a Novel ATP-Binding Cassette Subfamily G Member 5 Compound Heterozygous Mutation.

Authors:  Ming-Fang Shen; Ya-Nan Hu; Wei-Xiang Chen; Li-Sheng Liao; Min Wu; Qiu-Yan Wu; Jian-Hui Zhang; Yan-Ping Zhang; Jie-Wei Luo; Xin-Fu Lin
Journal:  Front Cardiovasc Med       Date:  2022-04-26

3.  Prospective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design.

Authors:  Hayato Tada; Tomoyuki Kurashina; Masatsune Ogura; Misa Takegami; Yoshihiro Miyamoto; Hidenori Arai; Mariko Harada-Shiba; Shun Ishibashi
Journal:  J Atheroscler Thromb       Date:  2021-10-22       Impact factor: 4.394

Review 4.  2022 Consensus statement on the management of familial hypercholesterolemia in Korea.

Authors:  Chan Joo Lee; Minjae Yoon; Hyun-Jae Kang; Byung Jin Kim; Sung Hee Choi; In-Kyung Jeong; Sang-Hak Lee
Journal:  Korean J Intern Med       Date:  2022-07-27       Impact factor: 3.165

Review 5.  2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea.

Authors:  Chan Joo Lee; Minjae Yoon; Hyun-Jae Kang; Byung Jin Kim; Sung Hee Choi; In-Kyung Jeong; Sang-Hak Lee
Journal:  J Lipid Atheroscler       Date:  2022-07-07

Review 6.  Features of chinese patients with sitosterolemia.

Authors:  Zhizi Zhou; Xueying Su; Yanna Cai; Tzer Hwu Ting; Wen Zhang; Yunting Lin; Aijing Xu; Xiaojian Mao; Chunhua Zeng; Li Liu; Xiuzhen Li
Journal:  Lipids Health Dis       Date:  2022-01-18       Impact factor: 3.876

Review 7.  Individualized Treatment for Patients With Familial Hypercholesterolemia.

Authors:  Hayato Tada; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Lipid Atheroscler       Date:  2022-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.